Velocity Clinical Research (“Velocity”) continues its acquisitive streak announcing the purchase of two multi-site companies, VitaLink Research (“VitaLink”) and the National Research Institute (“NRI”) for…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.